A therapeutic role for BLyS antagonists

Abstract

B lymphocytestimulator (BLyS) is a vital B cell survivalfactor. Overexpressionof BLyS in mice may lead to systemic lupus erythematosus (SLE)-like disease, and treatment of bona fide SLE mice with BLyS antagonists ameliorates disease progression and enhances survival. BLyS overexpression is common in human SLE, and results from a phase I clinical trial with a BLyS antagonistin human SLE have shown the antagonist to be biologicallyactive and safe. These features collectivelypoint to BLyS as an attractive therapeutic target in human disease.

Keywords

APRIL B cells biologic antagonists BLyS SLE

References

Moore PA , Belvedere O , Orr A et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator . Science 1999; 285: 260-263 .

Shu H-B , Hu W-H , Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens . J Leukocyte Biol 1999; 65: 680-683 .

Schneider P , MacKay F , Steiner V et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth . J Exp Med 1999; 189: 1747-1756 .

Mukhopadhyay A , Ni J , Zhai Y , Yu G-L , Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kB, and c-Jun NH2-terminal kinase . J Biol Chem 1999; 274: 15978-15981 .

Tribouley C , Wallroth M , Chan V et al. Characterization of a new member of the TNF family expressed on antigen presenting cells . Biol Chem 1999; 380: 1443-1447 .

Gross JA , Johnston J , Mudri S et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease . Nature 2000; 404: 995-999 .

Nardelli B , Belvedere O , Roschke V et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells . Blood 2001; 97: 198-204 .

Kanakaraj P , Migone T-S , Nardelli B et al. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-kB and ELF-1 . Cytokine 2001; 13: 25-31 .

Liu Y , Xu L , Opalka N , Kappler M , Shu H-B , Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands . Cell 2002; 108: 383-394 .

10.

Kim HM , Yu KS , Lee ME et al. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation . Nat Struct Biol 2003; 10: 342-348 .

11.

Liu Y , Hong X , Kappler J et al. Ligand-receptor binding revealed by the TNF family member TALL-1 . Nature 2003; 423: 49-56 .

12.

Karpusas M , Cachero TG , Qian F et al. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes . J Mol Biol 2002; 315: 1145-1154 .

13.

Oren DA , Li Y , Volovik Y et al. Structural basis of BLyS receptor recognition . Nat Struct Biol 2002; 9: 288-292 .

14.

Scapini P , Nardelli B , Nadali G et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS . J Exp Med 2003; 197: 297-302 .

15.

Litinskiy MB , Nardelli B , Hilbert DM et al. DCs induce CD40- independent immunoglobulin class switching through BLyS and APRIL . Nat Immunol 2002; 3: 822-829 .

16.

Laabi Y , Gras M-P , Brouet J-C , Berger R , Larsen C-J , Tsapis A. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed . Nucleic Acids Res 1994; 22: 1147-1154 .

17.

von Bülow G-U , Bran RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily . Science 1997; 278: 138-141 .

18.

Thompson JS , Bixler SA , Qian F et al. BAFF-R, a novel TNF receptor that specifically interacts with BAFF . Science 2001; 293: 2108-2111 .

19.

Yan M , Brady JR , Chan B et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency . Curr Biol 2001; 11: 1547-1552 .

20.

Xia X-Z , Treanor J , Senaldi G et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation . J Exp Med 2000; 192: 137-143 .

21.

Novak AJ , Darce JR , Arendt BK et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival . Blood 2004; 103: 689-694 .

22.

Avery DT , Kalled SL , Ellyard JI et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells . J Clin Invest 2003; 112: 286-297 .

23.

Shu H-B , Johnson H. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1 . Proc Natl Acad Sci USA 2000; 97: 9156-9161 .

24.

Hatzoglou A , Roussel J , Bourgeade M-F et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase . J Immunol 2000; 165: 1322-1330 .

25.

Xu L-G , Shu H-B. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kB activation and IL-10 production . J Immunol 2002; 169: 6883-6889 .

26.

Hikida M , Johmura S , Hashimoto A , Takezaki M , Kurosaki T. Coupling between B cell receptor and phospholipase C-g2 is essential for mature B cell development . J Exp Med 2003; 198: 581-589 .

27.

Claudio E , Brown K , Park S , Wang H , Siebenlist U. BAFF-induced NEMO-independent processing of NK-kB2 in maturing B cells . Nat Immunol 2002; 3: 958-965 .

28.

Kayagaki N , Yan M , Seshasayee D et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kB2 . Immunity 2002; 10: 515-524 .

29.

Hatada EN , Do RKG , Orlofsky A et al. NF-kB1 p50 is required for BLyS attentuation of apoptosis but dispensible for processing of NF-kB2 p100 to p52 in quiescent mature B cells . J Immunol 2003; 171: 761-768 .

30.

Thompson JS , Schneider P , Kalled SL et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population . J Exp Med 2000; 192: 129-135 .

31.

Do RKG , Hatada E , Lee H , Tourigny MR , Hilbert D , Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response . J Exp Med 2000; 192: 953-964 .

32.

Batten M , Groom J , Cachero TG et al. BAFF mediates survival of peripheral immature B lymphocytes . J Exp Med 2000; 192: 1453-1465 .

33.

Harless SM , Lentz VM , Sah AP et al. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers . Curr Biol 2001; 11: 1986-1989 .

34.

Hsu BL , Harless SM , Lindsley RC , Hilbert DM , Cancro MP. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators . J Immunol 2002; 168: 5993-5996 .

35.

Amanna IJ , Dingwall JP , Hayes CE. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice . J Immunol 2003; 170: 4593-4600 .

36.

Gross JA , Dillon SR , Mudri S et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS . Immunity 2001; 15: 289-302 .

37.

Schiemann B , Gommerman JL , Vora K et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway . Science 2001; 293: 2111-2114 .

38.

Xu S , Lam D-P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensible for humoral immune responses . Mol Cell Biol 2001; 21: 4067-4074 .

39.

von Bülow G-U , van Deursen JM , Bram RJ. Regulation of the T-independent humoral response by TACI . Immunity 2001; 14: 573-582 .

40.

Yan M , Wang H , Chan B et al. Activation and accumulation of B cells in TACI-deficient mice . Nat Immunol 2001; 2: 638-643 .

41.

Seshasayee D , Valdez P , Yan M , Dixit VM , Tumas D , Grewal IS. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor . Immunity 2003; 18: 279-288 .

42.

Hahn BH , Tsao BP. Antibodies to DNA. In Wallace DJ , Hahn BH , eds Dubois’ lupus erythematosus. 5th edition. Baltimore: Williams & Wilkins , 1997: 407-422.

43.

Mackay F , Woodcock SA , Lawton P et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations . J Exp Med 1999; 190: 1697-1710 .

44.

Khare SD , Sarosi I , Xia X-Z et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice . Proc Natl Acad Sci USA 2000; 97: 3370-3375 .

45.

Zhang J , Roschke V , Baker KP et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus . J Immunol 2001; 166: 6-10 .

46.

Cheema GS , Roschke V , Hilbert DM , Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases . Arthritis Rheum 2001; 44: 1313-1319 .

47.

Stohl W , Metyas S , Tan S-M et al. B lymphocyte stimulator (BLyS) overexpression in patients with systemic lupus erythematosus: longitudinal observations . Arthritis Rheum 2003; 48: 3475-3486 .

48.

Petri M , Stohl W , Chatham W et al. BLyS plasma concentrations correlate with disease activity and levels of anti-dsDNA autoantibodies and immunoglobulins (Ig) in a SLE patient observational study . Arthritis Rheum 2003; 48: S655-S655 .

49.

Baker KP , Edwards BM , Main SH et al. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes BLyS bioactivities . Arthritis Rheum 2003; 48: 3253-3265 .

50.

Furie R , Stohl W , Ginzler E et al. Safety, pharmacokinetic and pharmacodynamic results of a phase 1 single and double dose-escalation study of Lymphostat-B (human monoclonal antibody to BLyS) in SLE patients . Arthritis Rheum 2003; 48: S377-S377 .

51.

Gavin AL , Aït-Azzouzene D , Ware CF , Nemazee D. DBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF . J Biol Chem 2003; 278: 38220-38228 .

52.

Hahne M , Kataoka T , Schröter M et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth . J Exp Med 1998; 188: 1185-1190 .

53.

Marsters SA , Yan M , Pitti RM , Haas PE , Dixit VM , Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the receptor homologues BCMA and TACI . Curr Biol 2000; 10: 785-788 .

54.

Yu G , Boone T , Delaney J et al. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity . Nat Immunol 2000; 1: 252-256 .

55.

Wu Y , Bressette D , Carrell JA et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS . J Biol Chem 2000; 275: 35478-35485 .

56.

Rennert P , Schneider P , Cachero TG et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth . J Exp Med 2000; 192: 1677-1683 .

57.

Craxton A , Magaletti D , Ryan EJ , Clark EA. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF . Blood 2003; 101: 4464-4471 .

58.

Stein JV , López-Fraga M , Elustondo FA et al. APRIL modulates B and T cell immunity . J Clin Invest 2002; 109: 1587-1598 .

59.

Roschke V , Sosnovtseva S , Ward CD et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases . J Immunol 2002; 169: 4314-4321 .

60.

Stohl W , Metyas S , Tan S-M et al. Inverse association between circulating APRIL levels and serologic and clinical disease activity in patients with systemic lupus erythematosus . Ann Rheum Dis 2004; In press.